ADMS - Adamas Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts9999
Avg. Estimate-0.61-0.54-2.18-1.35
Low Estimate-0.75-0.78-2.93-2.3
High Estimate-0.52-0.1-1.29-0.2
Year Ago EPS-0.9-0.99-3.8-2.18
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts9999
Avg. Estimate15.46M19.35M71.17M101.14M
Low Estimate12.5M13.5M55.48M82.5M
High Estimate18.1M33.36M99.34M128.41M
Year Ago SalesN/A13.93M54.64M71.17M
Sales Growth (year/est)N/A38.90%30.30%42.10%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.98-0.89-0.85-0.77
EPS Actual-0.9-0.99-0.83-0.59
Difference0.08-0.10.020.18
Surprise %8.20%-11.20%2.40%23.40%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.61-0.54-2.18-1.35
7 Days Ago-0.61-0.54-2.18-1.35
30 Days Ago-0.61-0.54-2.18-1.35
60 Days Ago-0.64-0.52-2.27-1.51
90 Days Ago-0.67-0.53-2.32-1.5
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesADMSIndustrySector(s)S&P 500
Current Qtr.32.20%N/AN/AN/A
Next Qtr.45.50%N/AN/AN/A
Current Year42.60%N/AN/AN/A
Next Year38.10%N/AN/AN/A
Next 5 Years (per annum)46.30%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A